DS
AURA icon

David Shaw’s Aura Biosciences AURA Stock Holding History

David Shaw’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Buy
+67,405
New +$482K ﹤0.01% 4206
2024
Q4 		– Sell
-37,883
Closed -$338K – 4403
2024
Q3 		$338K Sell
37,883
-31,616
-45% -$271K ﹤0.01% 3920
2024
Q2 		$525K Sell
69,499
-25,946
-27% -$190K ﹤0.01% 3596
2024
Q1 		$749K Buy
95,445
+35,381
+59% +$293K ﹤0.01% 3272
2023
Q4 		$532K Buy
+60,064
New +$509K ﹤0.01% 3485

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

David Shaw's AURA Position: Q2 2026 in Review

David Shaw opened a new position in Aura Biosciences (AURA) in Q2 2026: 67,405 shares worth $479K. The stake represents ﹤0.01% of the portfolio and ranks #4206 among its holdings. This is a return to the name: David Shaw previously reported a position in AURA as recently as Q3 2024.

David Shaw first reported a position in AURA in Q4 2023 and has held it in 5 quarters since. The position peaked at $749K in Q1 2024. 145 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • David Shaw held 67,405 shares of Aura Biosciences worth $479K as of Q2 2026.
  • Aura Biosciences was a new David Shaw position in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4206 holding.
  • David Shaw first reported a position in Aura Biosciences in Q4 2023 and has held it in 5 quarters since.
  • David Shaw's Aura Biosciences position peaked at $749K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.